| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 04/29/2026 | ±2.7% | +2.1% | over-priced |
| 02/18/2026 | ±3.4% | +9.4% | under-priced |
| 10/29/2025 | ±1.9% | -11.5% | under-priced |
| 07/30/2025 | ±1.4% | -7.4% | under-priced |
| 04/30/2025 | ±2.5% | -8.4% | under-priced |
| 02/19/2025 | ±2.7% | +12.6% | under-priced |
| 10/30/2024 | ±1.7% | +23.3% | under-priced |
| 07/31/2024 | ±1.8% | -4.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $2.09 | $1.8B | $405M |
| Q4 FY2025 | — | $2.1B | $529M |
| Q3 FY2025 | $2.08 | $1.8B | $402M |
| Q2 FY2025 | $2.07 | $1.8B | $401M |
GRMN (GRMN) reports imminently, with the next report estimated for 10/26/2026. Across the last 8 reports, options priced an average ±2.3% earnings move while the stock actually moved 9.9% on average — the market has tended to under-price GRMN's earnings risk. Fundamentals into the print: EPS up 21.5% year-over-year, revenue up 14.2%. QuantLogix's live 5-factor engine currently reads GRMN as a neutral at 54/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →